Journal article · 2024 · Open access
Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications
PLoS Biology, 22(6), e3002667 · Published 13 June 2024 · DOI 10.1371/journal.pbio.3002667
In brief
“Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications” is a 2024 journal article by Benjamin Victor Ineichen and 4 co-authors, published in PLoS Biology. OpenAlex counts 121 citations as of 15 November 2026, which puts it in the top 2% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at PLoS Biology.
- Citations
- 121
- Most cited in
- 2026 (75)
- Field-weighted impact
- 60.56
- References
- 64
- Authors
- 5
Abstract
There is an ongoing debate about the value of animal experiments to inform medical practice, yet there are limited data on how well therapies developed in animal studies translate to humans. We aimed to assess 2 measures of translation across various biomedical fields: (1) The proportion of therapies which transition from animal studies to human application, including involved timeframes; and (2) the consistency between animal and human study results. Thus, we conducted an umbrella review, including English systematic reviews that evaluated the translation of therapies from animals to humans. Medline, Embase, and Web of Science Core Collection were searched from inception until August 1, 2023. We assessed the proportion of therapeutic interventions advancing to any human study, a randomized controlled trial (RCT), and regulatory approval. We meta-analyzed the concordance between animal and human studies. The risk of bias was probed using a 10-item checklist for systematic reviews. We included 122 articles, describing 54 distinct human diseases and 367 therapeutic interventions. Neurological diseases were the focus of 32% of reviews. The overall proportion of therapies progressing from animal studies was 50% to human studies, 40% to RCTs, and 5% to regulatory approval. Notably, our meta-analysis showed an 86% concordance between positive results in animal and clinical studies. The median transition times from animal studies were 5, 7, and 10 years to reach any human study, an RCT, and regulatory approval, respectively. We conclude that, contrary to widespread assertions, the rate of successful animal-to-human translation may be higher than previously reported. Nonetheless, the low rate of final approval indicates potential deficiencies in the design of both animal studies and early clinical trials. To ameliorate the efficacy of translating therapies from bench to bedside, we advocate for enhanced study design robustness and the reinforcement of generalizability.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ineichen, B. V., Furrer, E., Grüninger, S., Zürrer, W. E., & Macleod, M. R. (2024). Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications. PLoS Biology, 22(6), e3002667. https://doi.org/10.1371/journal.pbio.3002667
MLA 9
Ineichen, Benjamin Victor, et al. “Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications.” PLoS Biology, vol. 22, no. 6, 2024, p. e3002667. https://doi.org/10.1371/journal.pbio.3002667.
Chicago
Ineichen, Benjamin Victor, Eva Furrer, Servan Grüninger, Wolfgang Emanuel Zürrer, and Malcolm Robert Macleod. 2024. “Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications.” PLoS Biology 22 (6): e3002667. https://doi.org/10.1371/journal.pbio.3002667.
Harvard
Ineichen, B. V. et al. (2024) ‘Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications’, PLoS Biology, 22(6), p. e3002667. doi:10.1371/journal.pbio.3002667.
IEEE
B. V. Ineichen, E. Furrer, S. Grüninger, W. E. Zürrer, and M. R. Macleod, “Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications,” PLoS Biology, vol. 22, no. 6, p. e3002667, 2024, doi: 10.1371/journal.pbio.3002667.
BibTeX
@article{ineichen2024analysis,
title = {{Analysis of animal-to-human translation shows that only 5\% of animal-tested therapeutic interventions obtain regulatory approval for human applications}},
author = {Ineichen, Benjamin Victor and Furrer, Eva and Grüninger, Servan and Zürrer, Wolfgang Emanuel and Macleod, Malcolm Robert},
journal = {PLoS Biology},
year = {2024},
volume = {22},
number = {6},
pages = {e3002667},
doi = {10.1371/journal.pbio.3002667},
url = {https://doi.org/10.1371/journal.pbio.3002667}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 8 | |
| 2025 | 38 | |
| 2026 | 75 |
Its field-weighted citation impact is 60.56: it has been cited 60.56 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- animal-to-human translation
- translational research
- animal experimentation
- regulatory approval
- therapeutic interventions
- randomized controlled trials
- neurological disorders
- bench-to-bedside
Work with this paper
Most-cited papers in Veterinary
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysTim R. Mosmann · Journal of Immunological Methods · 1983 · 57,115 citations
- Guide for the Care and Use of Laboratory Animals: Eighth EditionNational Research Council · National Academies Press eBooks · 2011 · 16,572 citations
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningPhilip Skehan, Ritsa Storeng, Dominic A. Scudiero and 7 more · JNCI Journal of the National Cancer Institute · 1990 · 9,860 citations
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchCarol Kilkenny, William J. Browne, Innes C. Cuthill and 2 more · PLoS Biology · 2010 · 7,617 citations
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal researchNathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia and 25 more · PLoS Biology · 2020 · 6,761 citations
Questions about this paper
How do I cite this paper in APA style?
Ineichen, B. V., Furrer, E., Grüninger, S., Zürrer, W. E., & Macleod, M. R. (2024). Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications. PLoS Biology, 22(6), e3002667. https://doi.org/10.1371/journal.pbio.3002667
How many times has this paper been cited?
121 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at PLoS Biology.
Who wrote this paper?
Benjamin Victor Ineichen, Eva Furrer, Servan Grüninger, Wolfgang Emanuel Zürrer, Malcolm Robert Macleod.
What is the DOI of this paper?
10.1371/journal.pbio.3002667. The permanent link is https://doi.org/10.1371/journal.pbio.3002667.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.